Peptides · Regulatory transition in progress

From the gray market to a regulated 503A pathway.

Browse every peptide we can prepare. Filter by what you're treating, current regulatory status, or form. The FDA's pending July 2026 decision is expected to expand 503A access; RonanRx is the pharmacy partner for clinics ready when it does.

Get on the partner list Other compounded medications →

One clinician's hand offering a labeled RonanRx peptide vial to a second clinician, against a warm cream background.

Category 2 peptideSubject to evolving FDA reviewFDA review process

BPC-157

Physicians may submit patient-specific prescription requests for pharmacy review.

Available with valid Rx

Sermorelin

GHRH analog available under a valid patient-specific prescription.

Category 2 peptide

Ipamorelin

Availability is determined case by case after pharmacy review.

Category 2 peptide

MOTS-C

This ingredient is part of an evolving FDA review process.

Category 2 peptide

TB-500

Supporting clinical rationale may be requested.

Available with valid Rx

Tesamorelin

Prescriber-directed requests move through pharmacist review.

BROWSE 24 PEPTIDES

Showing 24 of 24

Sort by

		Used for	Form
5-Amino 1MQ	NNMT inhibitor (small molecule)	Metabolic, Longevity	ORAL	Subject to evolving FDA review
AOD-9604	GH C-terminal fragment	GH axis, Metabolic	INJ	Subject to evolving FDA review
BPC-157	Pentadecapeptide (research peptide)	Recovery	INJ	Subject to evolving FDA review
Bremelanotide / PT-141	Melanocortin receptor agonist	Sexual health	INJ	Available with valid Rx
CJC-1295	GHRH analog (long-acting peptide)	GH axis	INJ	Subject to evolving FDA review
Compounded Semaglutide	GLP-1 receptor agonist	Metabolic	INJ	Valid patient-specific Rx required
Compounded Tirzepatide	Dual GIP/GLP-1 receptor agonist	Metabolic	INJ	Valid patient-specific Rx required
DSIP, Delta Sleep-Inducing Peptide	Sleep-related nonapeptide	Sleep	INJ	Subject to evolving FDA review
Epitalon / Epithalon	Pineal tetrapeptide	Longevity, Sleep	INJ	Subject to evolving FDA review
GHRP-2 / GHRP-6	GH-releasing peptide	GH axis	INJ	Subject to evolving FDA review
Hexarelin	GH-secretagogue hexapeptide	GH axis	INJ	Subject to evolving FDA review
Ipamorelin	Selective ghrelin receptor agonist (peptide)	GH axis	INJ	Subject to evolving FDA review
KPV	Tripeptide (α-MSH fragment)	Recovery, Skin	TOPICAL · INJ · ORAL	Subject to evolving FDA review
LL-37	Cathelicidin antimicrobial peptide	Immune	INJ · TOPICAL	Subject to evolving FDA review
MK-677 / Ibutamoren	Orally active GH secretagogue (small molecule)	GH axis	ORAL	Subject to evolving FDA review
MOTS-C	Mitochondrial-encoded peptide	Metabolic	INJ	Subject to evolving FDA review
Pentadeca Arginate (PDA)	Pentadecapeptide arginate	Recovery	INJ · ORAL	Subject to evolving FDA review
Selank	Tuftsin-derived heptapeptide	Cognition	INJ · TOPICAL	Subject to evolving FDA review
Semax	ACTH-derived peptide	Cognition	INJ · TOPICAL	Subject to evolving FDA review
Sermorelin	GHRH analog (peptide)	GH axis, Longevity	INJ	Valid patient-specific Rx required
TB-500 / Thymosin Beta-4	Thymosin beta-4 peptide fragment	Recovery	INJ	Subject to evolving FDA review
Tesamorelin	GHRH analog (peptide)	GH axis	INJ	Valid patient-specific Rx required
Thymosin Alpha-1 / Thymalin	Thymic peptide (immunomodulatory)	Immune, Longevity	INJ	Subject to evolving FDA review
Vasoactive Intestinal Peptide (VIP)	Endogenous neuropeptide	Sleep	INJ	Subject to evolving FDA review